7U5 Stock Overview
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BIOTON S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.70 |
| 52 Week High | zł0.85 |
| 52 Week Low | zł0.70 |
| Beta | 0.10 |
| 11 Month Change | -7.81% |
| 3 Month Change | -13.11% |
| 1 Year Change | -8.66% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -13.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7U5 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -2.2% | -0.7% | -0.02% |
| 1Y | -8.7% | -17.2% | 8.2% |
Return vs Industry: 7U5 exceeded the German Biotechs industry which returned -17.5% over the past year.
Return vs Market: 7U5 underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| 7U5 volatility | |
|---|---|
| 7U5 Average Weekly Movement | 2.5% |
| Biotechs Industry Average Movement | 6.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7U5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7U5's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 357 | Jeremy Launders | www.bioton.pl |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
| 7U5 fundamental statistics | |
|---|---|
| Market cap | €62.19m |
| Earnings (TTM) | -€1.34m |
| Revenue (TTM) | €40.97m |
1.5x
P/S Ratio-46.5x
P/E RatioIs 7U5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7U5 income statement (TTM) | |
|---|---|
| Revenue | zł177.60m |
| Cost of Revenue | zł114.72m |
| Gross Profit | zł62.88m |
| Other Expenses | zł68.68m |
| Earnings | -zł5.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.068 |
| Gross Margin | 35.40% |
| Net Profit Margin | -3.27% |
| Debt/Equity Ratio | 6.8% |
How did 7U5 perform over the long term?
See historical performance and comparison